Log In
Print this Print this

DiaVacs dendritic cell therapy

  Manage Alerts
Collapse Summary General Information
Company DiaVacs Inc.
DescriptionDendritic cell therapy
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Non-stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today